Zinc-responsive peptides, and methods of use thereof
Described herein are compounds and methods useful in the detection of, e.g., Zn 2+ , in vitro and in vivo. The compounds include amino acids and peptides functionalized with a moiety that binds, e.g., Zn 2+ . The peptides may be further functionalized with a detectable moiety. The peptides may also comprise amino acid sequences known to localize extracellularly or in specific areas within a cell.
1. A compound, comprising a sensor moiety, a first linker, and a first amino acid, wherein the first amino acid is a natural amino acid or a non-natural α-amino acid; and the sensor moiety is selected from the group consisting of
wherein, independently for each occurrence,
X 1 is —H, —F, or —Cl;
X 2 is —H, —F, —Cl, —CO 2 R 1 , —C(O)-(first linker), -(first linker), —NR 1 -(first linker), or —S-(first linker), wherein at least one instance of X 2 is —C(O)-(first linker), -(first linker), —NR 1 -(first linker), or —S-(first linker);
X 3 is —H, —F, —Cl, or —OR 1 ;
R 1 is —H or alkyl;
R 2 is —H or phenyl;
R 3 is H, alkyl, or —CO 2 H;
R 4 is H or alkyl; and
X 4 is —C(O)-(first linker), -(first linker), —NR 1 -(first linker), or —S-(first linker).
2. The compound of claim 1 , wherein the first amino acid is lysine, 2,3-diaminopropionic acid, or glycine.
3. The compound of claim 1 , wherein the first linker is an amide bond, a disulfide bond, a thioether bond, a thiourea, or a triazole.
4. The compound of claim 1 , wherein the compound has the following formula:
5. The compound of claim 1 , wherein the compound has the following formula:
6. The amino acid compound of claim 1 , wherein the compound is selected from the group consisting of
7. The compound of claim 1 , further comprising a second amino acid, wherein the second amino acid is a natural amino acid or a non-natural amino acid.
8. The compound of claim 1 , wherein the compound has the following formula (N-terminus→C-terminus):
(Xaa) p -first amino acid-(Xaa) p (SEQ ID NO: 9)
wherein, independently for each occurrence,
the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
p is 0-10 inclusive;
at least one occurrence of p is not zero; and
Xaa is a natural amino acid or a non-natural amino acid.
9. The compound of claim 1 , wherein the compound comprises the following formula:
RGD-first amino acid-first linker-sensor moiety (SEQ ID NO: 10)
wherein
the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
the first amino acid is 2,3-diaminopropionic acid;
the first linker is an amide bond; and
the sensor moiety is
10. The compound of claim 1 , wherein the compound has the following formula (N-terminus→C-terminus):
H 3 C—(CH 2 ) 14 —C(O)-(Xaa) p -first amino acid-NH 2 (SEQ ID NO: 11)
wherein
p is 0-10 inclusive;
the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
the first amino acid is lysine;
the first linker is an amide bond; and
the sensor moiety is
11. The compound of claim 1 , wherein the compound has the following formula (N-terminus→C-terminus):
sensor moiety-first linker-first amino acid-(Xaa) p -NH 2 (SEQ ID NO: 12)
wherein
p is 0-10 inclusive;
the sensor moiety is covalently bonded to the N-terminus of the first amino acid via the first linker;
the first amino acid is cyclohexylalanine;
the first linker is an amide bond; and
the sensor moiety is
12. The compound of claim 7 , wherein the compound further comprises a detectable moiety.
13. The compound of claim 12 , wherein the detectable moiety is a phosphorescent moiety or a fluorescent moiety.
14. The compound of claim 12 , wherein the detectable moiety is coumarin or a coumarin derivative.
15. The compound of claim 12 , wherein the detectable moiety is rhodamine or a rhodamine derivative.
16. The compound of claim 12 , wherein the compound comprises the following formula:
sensor moiety-first linker-first amino acid-(Xaa) p -second amino acid-(Xaa) p (SEQ ID NO: 13)
wherein, independently for each occurrence,
the sensor moiety is covalently bonded to the N-terminus of the first amino acid via the first linker, or the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
the detectable moiety is covalently bonded to the side chain of the second amino acid via a second linker;
p is 0-10 inclusive; and
Xaa is a natural amino acid or a non-natural amino acid.
17. The compound of claim 12 , wherein the compound comprises the following formula:
detectable moiety-second linker-second amino acid-(Xaa) p -first amino acid-(Xaa) p (SEQ ID NO: 14)
wherein, independently for each occurrence,
the detectable moiety is covalently bonded to the N-terminus of the second amino acid via the second linker, or the detectable moiety is covalently bonded to the side chain of the second amino acid via the second linker;
the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
p is 0-10 inclusive; and
Xaa is a natural amino acid or a non-natural amino acid.
18. The compound of claim 12 , wherein the compound comprises the following formula:
(Xaa) p -first amino acid-(Xaa) p -second amino acid-(Xaa) p (SEQ ID NO: 15)
Or
(Xaa) p -second amino acid-(Xaa) p -first amino acid-(Xaa) p (SEQ ID NO: 16)
wherein, independently for each occurrence,
the sensor moiety is covalently bonded to the side chain of the first amino acid via the first linker;
the detectable moiety is covalently bonded to the side chain of the second amino acid via a second linker;
p is 0-10 inclusive; and
Xaa is a natural amino acid or a non-natural amino acid.
19. The compound of claim 12 , wherein the compound comprises the following formula:
sensor moiety-first linker-first amino acid-PPP -second amino acid-Xaa (SEQ ID NO: 17)
wherein
the sensor moiety is
the first linker is an amide bond;
the first amino acid is glycine;
the second amino acid is lysine;
the detectable moiety is covalently bonded to the side chain of the second amino acid via a second linker;
the detectable moiety is a coumarin derivative;
the second linker is an amide bond; and
Xaa is a natural amino acid or a non-natural amino acid.
20. The compound of claim 12 , wherein the compound comprises the following formula:
sensor moiety-first linker-first amino acid-PPP -second amino acid-DDD (SEQ ID NO: 18)
wherein
the sensor moiety is
the first linker is an amide bond;
the first amino acid is 2,3-diaminopropionic acid;
the second amino acid is lysine;
the detectable moiety is covalently bonded to the side chain of the second amino acid via a second linker;
the detectable moiety is a coumarin derivative; and
the second linker is an amide bond.
21. A method of quantifying an amount of a substance in a cell, comprising the steps of:
contacting the cell with a detectable amount of a compound of claim 1 ; and
detecting a signal, wherein the signal emitted by the compound in the presence of the substance is different than the signal emitted by the compound in the absence of the substance.
22. The method of claim 21 , wherein the method is a method of quantifying an amount of a substance in a specific locale of a cell, comprising the steps of:
contacting the cell with a detectable amount of a compound of claim 1 ; and
detecting a signal from the specific locale of the cell, wherein the signal emitted by the compound in the presence of the substance is different than the signal emitted by the compound in the absence of the substance.
23. The method of claim 22 , wherein the specific locale in the cell is an intracellular probe, an extracellular probe, a trans-Golgi network, a mitochondrion, or an endoplasmic reticulum.
24. The method of claim 21 , wherein the substance is selected from the group consisting of Zn 2+ , nitric oxide, Ca + , Cu + , Cu 2+ , H + , hydrogen peroxide, hydrogen sulfide, and reactive oxygen species (ROS).
25. A method of quantifying an amount or determining a location of a substance in a subject, comprising the steps of:
administering to the subject a detectable amount of a compound of claim 1 ; and
detecting a signal, wherein the signal emitted by the compound in the presence of the substance is different than the signal emitted by the compound in the absence of the substance.
26. The method of claim 25 , wherein the location of the substance is the synaptic cleft, the intracellular space of the hippocampus, mossy fiber buttons of the hippocampus, the pancreas, or the prostate.
27. The method of claim 25 , wherein the subject is a mammal.
28. The method of claim 25 , wherein the substance is selected from the group consisting of Zn 2+ , nitric oxide, Ca 2+ , Cu + , Cu 2+ , H + , hydrogen peroxide, hydrogen sulfide, and reactive oxygen species (ROS).